At the outbreak of the pandemic, Gilead Sciences donated its remdesivir supply to the government. Now, the company has outlined the charges it will start billing for in July. Gilead stock continues to rally in 2020. Back in May, the FDA approved the emergency use of remdesivir, a drug created by Gilead Sciences (NASDAQ: GILD)…